Cargando…

HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer

Intratumoral human epidermal growth factor receptor 2 (HER2) heterogeneity has been reported in 16–36% of HER2-positive breast cancer and its clinical impact is under discussion. We examined the biological effects of HER2-heterogeneity on mouse models and analyzed metastatic brains by RNA sequence a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosonaga, Mari, Arima, Yoshimi, Sampetrean, Oltea, Komura, Daisuke, Koya, Ikuko, Sasaki, Takashi, Sato, Eiichi, Okano, Hideyuki, Kudoh, Jun, Ishikawa, Shumpei, Saya, Hideyuki, Ishikawa, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121890/ https://www.ncbi.nlm.nih.gov/pubmed/30042341 http://dx.doi.org/10.3390/ijms19082158

Ejemplares similares

RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis
por: Sato, Ryo, et al.
Publicado: (2017)

Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells
por: Hosonaga, Mari, et al.
Publicado: (2014)

Molecular and cellular mechanisms underlying brain metastasis of breast cancer
por: Hosonaga, Mari, et al.
Publicado: (2020)

Modeling phenotypes of malignant gliomas
por: Sampetrean, Oltea, et al.
Publicado: (2017)

ET-1 STEM CELL-BASED GENE THERAPY FOR MALIGNANT GLIOMA USING GENOME-EDITED HUMAN INDUCED PLURIPOTENT STEM CELLS
por: Tamura, Ryota, et al.
Publicado: (2022)

Lactate Reprograms Energy and Lipid Metabolism in Glucose-Deprived Oxidative Glioma Stem Cells
por: Minami, Noriaki, et al.
Publicado: (2021)

Organotypic brain explant culture as a drug evaluation system for malignant brain tumors
por: Minami, Noriaki, et al.
Publicado: (2017)

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
por: Wakatsuki, Takeru, et al.
Publicado: (2018)

Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells
por: Harigai, Ritsuko, et al.
Publicado: (2018)

Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue
por: Arima, Yoshimi, et al.
Publicado: (2023)

CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake
por: Kobayashi, Nana, et al.
Publicado: (2018)

CBMS-05 Biological and Pathological meaning of aneuploidy in mouse glioma stem sell
por: Negoto, Tetsuya, et al.
Publicado: (2020)

Author Correction: CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake
por: Kobayashi, Nana, et al.
Publicado: (2020)

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer
por: Yagi, Shusuke, et al.
Publicado: (2018)

HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
por: Ocaña, Alberto, et al.
Publicado: (2020)

Machine Learning Methods for Histopathological Image Analysis
por: Komura, Daisuke, et al.
Publicado: (2018)

Meet the authors: Daisuke Komura and Shumpei Ishikawa
por: Komura, Daisuke, et al.
Publicado: (2023)

HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285
por: Takagi, Shinji, et al.
Publicado: (2014)

HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
por: Kaito, Akio, et al.
Publicado: (2019)

Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts
por: Umeyama, Kazuhiro, et al.
Publicado: (2016)

Visualization of spatiotemporal dynamics of human glioma stem cell invasion
por: Tamura, Ryota, et al.
Publicado: (2019)

Targeting of cancer stem cells by differentiation therapy
por: Arima, Yoshimi, et al.
Publicado: (2020)

2-Nitroimidazoles induce mitochondrial stress and ferroptosis in glioma stem cells residing in a hypoxic niche
por: Koike, Naoyoshi, et al.
Publicado: (2020)

Protein co-expression networks identified from HOT lesions of ER+HER2–Ki-67high luminal breast carcinomas
por: Yamada, Kimito, et al.
Publicado: (2021)

Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
por: Ishimine, Yu, et al.
Publicado: (2015)

The Clinical Importance of the Heterogeneity of HER2 neu
por: Davila, Enrique, et al.
Publicado: (2010)

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
por: Kurozumi, Sasagu, et al.
Publicado: (2016)

Regulatory roles of fibronectin and integrin α5 in reorganization of the actin cytoskeleton and completion of adipogenesis
por: Uetaki, Megumi, et al.
Publicado: (2022)

Gene therapy using genome‐edited iPS cells for targeting malignant glioma
por: Tamura, Ryota, et al.
Publicado: (2022)

Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Patritumab deruxtecan (HER3-DXd), a novel HER3 directed antibody drug conjugate, exhibits in vitro activity against breast cancer cells expressing HER3 mutations with and without HER2 overexpression
por: Koyama, Kumiko, et al.
Publicado: (2022)

Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer
por: Griguolo, Gaia, et al.
Publicado: (2019)

Prognostic implications of HER2 heterogeneity in gastric cancer
por: Motoshima, Shigenobu, et al.
Publicado: (2018)

Downregulation of PD-L1 via FKBP5 by celecoxib augments antitumor effects of PD-1 blockade in a malignant glioma model
por: Yamaguchi, Izumi, et al.
Publicado: (2019)

Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer
por: Yamauchi, Teruo, et al.
Publicado: (2018)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021)

HER kinase inhibition in patients with HER2- and HER3-mutant cancers
por: Hyman, David M., et al.
Publicado: (2018)

Immune repertoire profiling for disease pathobiology
por: Katoh, Hiroto, et al.
Publicado: (2022)

Blocking COX-2 induces apoptosis and inhibits cell proliferation via the Akt/survivin- and Akt/ID3 pathway in low-grade-glioma
por: Sato, Aya, et al.
Publicado: (2017)

Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d
por: Semba, Takashi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c2joseb5s0quaikp8r1tidr2bk